Table 1 Patient characteristics and outcomes of those who developed pulmonary cavitation

Age range

50–59

40–49

60–69

40–49

60–69

50–59

40–49

30–39

40–49

50–59

30–39

40–49

BMI

30.9

30.4

31.3

29.2

25.1

29.4

26.3

21.5

30.1

19.8

24

27.7

Comorbidities

DM, HT

HT

DM

DM

COPD

HT

HT

DM, HT

DM

DM

DM

On admission

 Time from symptom onset to intubation (days)

6

12

9

7

5

5

8

15

3

9

10

8

 P/F ratio

48.8

41.6

49.7

33.0

46.1

47.0

65.3

41.8

70.5

100.1

109.4

104.5

 SOFA score (points)

24

21

24

25

23

23

16

21

25

23

18

17

 Neutropenia

Y

 Leucocytes (× 10 * 9/L)

0.49

1.35

0.3

2.78

0.6

1.1

1.66

1.03

0.46

2.91

1.62

2.63

During the admission

 NM blockade

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

 VTE

DVT and PE

PE

DVT

DVT

 CVA

Y

Y

 CRRT/IHD

Y

Y

Y

Y

Y

Y

Y

 ECMO

Y

Y

Y

 Proned

Y

Y

Y

Y

Y

Y

Y

Y

Y

 Tracheostomy

Y

Y

Y

Y

Y

Y

Y

Y

 Days of systemic CS

17

15

19

24

11

14

14

25

18

9

6

5

 + ve fungal cultures or serology

Y

Y

Y

Y

Y

 Treated for fungal infection

Y

Y

Y

Y

Y

Y

Y

Y

 Duration of hospital stay (days)

37

25

53

33

53

74

101

133

57

56

47

40

Outcome

Deceased

Deceased

Deceased

Deceased

Deceased

Deceased

Discharged home

Discharged home

Discharged home

Discharged home

Discharged home

Discharged home